Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6101
CALL
Grand Canyon Education
LOPE
$3.7B
| $1.45M | ﹤0.01% |
15,400
-10,500
| -41% | -$978K |
|
6102
PUT
Phillips Edison & Co
PECO
$5.14B
| $1.45M | ﹤0.01% |
43,400
+30,100
| +226% | +$1.02M |
|
6103
RELX
RELX
$58.5B
| $1.45M | ﹤0.01% |
53,826
+10,697
| +25% | +$308K |
|
6104
Coca-Cola Femsa
KOF
$22.8B
| $1.45M | ﹤0.01% |
26,210
-23,086
| -47% | -$1.29M |
|
|
BIOT
6105
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
| $1.45M | ﹤0.01% |
146,381
-749,281
| -84% | -$7.35M |
|
6106
PUT
Centrus Energy
LEU
$3.67B
| $1.45M | ﹤0.01% |
58,500
-15,400
| -21% | -$425K |
|
6107
Conduent
CNDT
$227M
| $1.45M | ﹤0.01% |
334,521
-796,033
| -70% | -$4M |
|
6108
CALL
Ingredion
INGR
$6.53B
| $1.45M | ﹤0.01% |
16,400
-100
| -0.6% | -$8.95K |
|
|
KW
6109
DELISTED
Kennedy-Wilson Holdings
KW
| $1.45M | ﹤0.01% |
76,292
-24,029
| -24% | -$517K |
|
6110
ProShares VIX Short-Term Futures ETF
VIXY
$206M
| $1.45M | ﹤0.01% |
3,959
+2,395
| +153% | +$876K |
|
6111
Mueller Industries
MLI
$14.7B
| $1.44M | ﹤0.01% |
108,428
-13,924
| -11% | -$189K |
|
|
BZUN
6112
PUT
Baozun
BZUN
$162M
| $1.44M | ﹤0.01% |
131,800
-2,100
| -2% | -$18.5K |
|
|
TRPA
6113
Hartford AAA CLO ETF
TRPA
$111M
| $1.44M | ﹤0.01% |
37,924
+15,893
| +72% | +$615K |
|
6114
Amphastar Pharmaceuticals
AMPH
$887M
| $1.44M | ﹤0.01% |
41,398
-196,485
| -83% | -$7.01M |
|
|
AMWD
6115
PUT
DELISTED
American Woodmark
AMWD
| $1.44M | ﹤0.01% |
32,000
-6,900
| -18% | -$333K |
|
6116
PUT
Comstock Resources
CRK
$3.98B
| $1.44M | ﹤0.01% |
119,100
+52,900
| +80% | +$875K |
|
|
INDF
6117
DELISTED
Nifty India Financials ETF
INDF
| $1.44M | ﹤0.01% |
49,337
+11,391
| +30% | +$356K |
|
|
MCW
6118
CALL
DELISTED
Mister Car Wash
MCW
| $1.44M | ﹤0.01% |
+132,100
| New | +$1.72M |
|
|
JCTR
6119
DELISTED
JPMorgan Carbon Transition US Equity ETF
JCTR
| $1.44M | ﹤0.01% |
28,335
-9,349
| -25% | -$515K |
|
|
BTWN
6120
CALL
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
| $1.43M | ﹤0.01% |
144,500
-32,000
| -18% | -$317K |
|
6121
CALL
Invesco Senior Loan ETF
BKLN
$6.8B
| $1.43M | ﹤0.01% |
70,500
+18,100
| +35% | +$384K |
|
|
RXDX
6122
PUT
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.43M | ﹤0.01% |
+50,600
| New | +$1.47M |
|
6123
Direxion Daily Energy Bear 2X ETF
ERY
$37M
| $1.43M | ﹤0.01% |
+27,260
| New | +$1.26M |
|
6124
Ring Energy
REI
$365M
| $1.43M | ﹤0.01% |
536,448
+195,201
| +57% | +$808K |
|
|
OIL
6125
CALL
DELISTED
iPath Pure Beta Crude Oil ETN
OIL
| $1.43M | ﹤0.01% |
41,600
-56,700
| -58% | -$1.98M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.